Flow-diverter treatment of recanalized ruptured blister aneurysms in the subacute phase: a report of two cases
Article information
Abstract
In Korea, flow-diverting stents (FDSs) for acutely ruptured aneurysms are not reimbursed by the National Health Insurance Service. FDS treatment may be considered when a blister aneurysm recanalizes after conventional reconstructive treatment. We describe two patients with ruptured blister aneurysms who were initially treated with stent-assisted coil embolization. Follow-up digital subtraction angiography (DSA) performed approximately 2 weeks after the procedure demonstrated early recanalization in both patients. After DSA confirmed the absence of vasospasm, a Pipeline embolization device was placed across the diseased parent-artery segment under dual antiplatelet therapy. No periprocedural ischemic complications were documented, and 6-month DSA confirmed complete occlusion in both patients. The modified Rankin Scale score at 6 months was 1 in both patients. In this report, “subacute phase” denotes flow-diverter deployment approximately 14 days after rupture during the index hospitalization, after initial aneurysm securing and angiographic exclusion of vasospasm. This staged rescue strategy may be reasonable for selected rapidly recanalized blister aneurysms when repeat coiling or additional conventional stenting is unlikely to provide durable reconstruction. However, no conclusions about safety can be drawn from two cases. Subacute FDS treatment for recanalized blister aneurysms has rarely been reported in Korea.
INTRODUCTION
Preventing rebleeding is the principal objective of early treatment after aneurysmal subarachnoid hemorrhage (SAH). Blister aneurysms are uncommon, broad-based lesions with fragile walls and may enlarge or change shape during the first several days after presentation, consistent with a dynamic arterial-wall pathology [1,2]. This behavior makes both microsurgical and endovascular treatment challenging.
Flow-diverting stents reconstruct the parent artery without requiring extensive manipulation within the aneurysm sac and can provide durable occlusion [3-6]. In ruptured aneurysms, however, delayed aneurysm occlusion and the need for dual antiplatelet therapy (DAPT) raise concerns regarding rebleeding, thromboembolism, and hemorrhagic complications [4-9].
Terminology regarding treatment timing is inconsistent across the literature; for example, ten Brinck et al. [7] included flow-diverter treatment performed within 15 days after rupture. Because the devices in the present cases were deployed within 14 days after rupture, we use the term “subacute phase” operationally to mean treatment during the index hospitalization after initial aneurysm securing and after follow-up digital subtraction angiography (DSA) confirmed the absence of vasospasm. The exact rupture-to-treatment chronology is summarized in Table 1.
We report two recanalized blister aneurysms treated with a Pipeline embolization device (PED) in this subacute setting after initial stent-assisted coil embolization.
Ethical statements
IRB approval and patient consent were waived due to the retrospective nature of this case report and the complete de-identification of patient data.
CASE REPORT
Case 1
A 57-year-old woman was referred from another hospital with SAH caused by a ruptured blister aneurysm of the right dorsal wall internal carotid artery (ICA). Initial DSA showed a 2.55×2.00×2.00 mm (Depth×Dome×Neck) blister aneurysm. Her initial clinical status was World Federation of Neurosurgical Societies (WFNS) grade 3 and Hunt and Hess grade 3.
Under general anesthesia and systemic heparinization (3,000 IU), stent-assisted coil embolization was performed on the rupture day. A Neuroform Atlas Stent System (4.5×30 mm; Stryker Neurovascular) was deployed to support coil embolization and reconstruct the parent artery. Immediate angiography demonstrated complete occlusion.
Follow-up DSA on post-rupture day 12, within 2 weeks after the initial procedure, demonstrated recanalization. No angiographic vasospasm was identified. On post-rupture day 14, a Pipeline Flex with Shield Technology (4.0×20 mm; Medtronic Neurovascular) was deployed across the diseased ICA segment.
For Case 1, no acute or delayed ischemic complication was identified. Complete aneurysm occlusion was confirmed on 6-month DSA. The 6-month modified Rankin Scale (mRS) score was 1, and the latest available follow-up was 1-year follow-up magnetic resonance, which also showed no recanalization (Fig. 1).
(A) Small blister aneurysm of the right internal carotid artery. (B) Stent-assisted coil embolization achieved complete occlusion of the blister aneurysm. (C) Recanalization of the blister aneurysm was observed after 2 weeks. (D) A second intervention was performed using a flow-diverting stent (FDS). (E) Complete occlusion of the blister aneurysm was achieved after the second intervention with the FDS.
Case 2
A 46-year-old man presented with SAH caused by a ruptured blister aneurysm of the ICA dorsal wall. The aneurysm measured 2.00×3.08×3.68 mm (Depth×Dome×Neck). His initial clinical status was WFNS grade 2 and Hunt and Hess grade 2.
Under general anesthesia, stent-assisted coil embolization was performed on the rupture day. A laser-cut stent (Enterprise 2VRD, 4.0×23 mm; Codman Neuro) and braided stents (LVIS, 4.5×23 mm; MicroVention; and Accero, 4.0×15 mm; Acandis) were implanted to support coil embolization. Immediate angiography showed complete occlusion of the aneurysm.
Follow-up DSA on post-rupture day 13, also within 2 weeks after the initial procedure, demonstrated recanalization without angiographic vasospasm. On post-rupture day 14, a Pipeline Flex with Shield Technology (3.5×20 mm; Medtronic Neurovascular) was delivered through the true lumen of the previously deployed stents and deployed across the diseased segment.
For Case 2, no acute or delayed ischemic complication was identified. Complete aneurysm occlusion was confirmed on 6-month DSA, and the 6-month mRS score was 1 (Fig. 2).
(A) Ruptured blister aneurysm. (B) Stent-assisted coil embolization using two types of stents. (C) Complete occlusion of the blister aneurysm. (D) Recanalization of the blister aneurysm after 2 weeks. (E) Pipeline embolization device (PED) deployed through the true lumen of the previously placed stent construct. (F) Complete occlusion of the blister aneurysm after the second intervention with the PED.
Antiplatelet management
After the initial stent-assisted coil embolization, both patients received DAPT. For both patients, the regimen was aspirin (loading dose 300 mg; maintenance 100 mg/day) and clopidogrel (loading dose 200 mg; maintenance 75 mg/day).
Platelet function testing was not performed. DAPT was continued for 6 months, followed by aspirin monotherapy.
DISCUSSION
Blister aneurysms are thought to arise from focal disruption of the arterial wall and can evolve rapidly in size and morphology [1,2]. Accordingly, the early recanalization seen in these two cases may have reflected progressive wall dissection or enlargement of the diseased segment rather than coil compaction alone. This mechanism also explains why an apparently complete immediate angiographic result after stent-assisted coiling may not be durable.
We selected flow diversion rather than repeat coiling or another conventional stent because both aneurysms recanalized within approximately 2 weeks despite initial stent-assisted coiling. Repeat coiling would have required renewed catheterization of a shallow, fragile sac without treating the underlying arterial-wall defect. Additional conventional stenting could increase metal coverage, but its reconstructive effect was considered less predictable than the dense endoluminal scaffold provided by a flow diverter. PED treatment was therefore intended to reconstruct the entire diseased parent-artery segment.
Published series and systematic reviews have described flow diversion for acutely ruptured aneurysms and ruptured blister aneurysms [5-12]. In a multicenter study of 44 patients treated within 15 days after rupture, ten Brinck et al. [7] emphasized careful patient selection because hemorrhagic and thromboembolic complications remained substantial. A systematic review by Rouchaud et al. [5] found that flow-diverter treatment of ruptured blister aneurysms achieved high follow-up occlusion but was associated with more thromboembolic events than non-flow-diverter endovascular treatment; rebleeding rates were not significantly different. These findings support cautious use rather than a general claim of safety.
Staged treatment has precedent. Princiotta et al. [13] described stent-assisted coiling followed by in-stent flow-diverter insertion for a blister aneurysm, and Khanna et al. [14] reported coil embolization followed by subacute flow diversion during the same hospitalization in 18 patients with ruptured aneurysms. The present cases differ in that early angiographic recanalization, rather than a preplanned staged strategy, prompted rescue flow diversion.
In Case 2, the PED delivery system was advanced through the true lumen of the previously implanted stents. This step is technically important because passage outside an existing stent lumen could impair PED expansion or apposition. Precise identification of the laser-cut and braided stents, their dimensions, and the lumen traversed is therefore included in the case description.
These observations are limited by the small sample size, absence of a comparator, and 6-month angiographic follow-up. The absence of a documented ischemic complication in two patients does not establish the safety of subacute flow diversion, particularly because outcomes depend on antiplatelet response, SAH severity, and the need for subsequent invasive procedures. Longer clinical and angiographic follow-up would be valuable. To our knowledge, this subacute rescue strategy for recanalized blister aneurysms has rarely been reported in Korea.
CONCLUSION
In two patients with ruptured blister aneurysms that recanalized shortly after stent-assisted coil embolization, subacute PED placement resulted in complete occlusion at 6 months without a documented periprocedural ischemic complication. Flow diversion may be considered as a rescue option in carefully selected cases when repeat coiling or additional conventional stenting is unlikely to provide durable reconstruction. These two cases do not establish safety, and longer follow-up is needed.
Notes
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
